Researchers used AlphaFold AI to redesign gene-editing proteins, reducing off-target effects that cause safety concerns in therapies. The team modified key areas of Cas proteins identified by the AI t…
Artificial intelligence has already saturated academia, with 88% of UK students using generative AI for assessments in 2025, up from 53% the prior year, according to the Higher Education Policy Instit…
Anthropic has opened applications for a grant program under its AI for Science initiative, offering up to $50,000 in Claude API credits to researchers working on rare genetic diseases. The program, an…
Google DeepMind philosopher Iason Gabriel works to anticipate the ethical fallout of AI, bridging the gap between AI safety and AI ethics. His 2020 paper on values and alignment argues that choosing w…
Google DeepMind has launched a bioresilience programme to use AI to prevent, detect and respond to biological threats, the London lab and its sister company Isomorphic Labs announced in a joint blog p…
Google DeepMind and Isomorphic Labs have announced a joint initiative on bioresilience, using AI to predict and defend against biological threats, building on AlphaFold technology. Isomorphic Labs, fo…
Google DeepMind and Isomorphic Labs released a joint approach to bioresilience, outlining how AI can prevent misuse of models, detect outbreaks, and accelerate response. The companies have advanced mo…
A study of 40 million papers found that scientists using AI publish more and advance faster, but AI-heavy research clusters around the same problems, reducing scientific diversity. The findings, publi…
Google DeepMind's AlphaFold 3 predicts interactions among proteins, DNA, RNA, ligands, and other biomolecules, while Isomorphic Labs introduced the Isomorphic Drug Design Engine (IsoDDE) for drug disc…
Nobel laureate John Jumper, co-creator of AlphaFold, left Google DeepMind for Anthropic to advance AI-for-science. Anthropic launched Claude Science, a research workbench, and opened grants for 50 pro…
A developer explains how the Transformer architecture, introduced by Google in 2017, replaced recurrent neural networks and LSTMs as the dominant paradigm in AI. The architecture processes all tokens …
The UN's first global AI science panel warned Wednesday that the window to govern artificial intelligence is closing, as the technology outpaces regulation. The preliminary report from the Independent…
Anthropic announced Claude Science, a new flagship product for scientific research, at an event for pharmaceutical executives and biotech founders on Tuesday. The product autonomously carries out work…
Anthropic launched an AI drug discovery program on May 5, 2025, offering free API credits to researchers in biology and life sciences. The company later launched Claude for Life Sciences and acquired …
Emily M. Bender, lead author of the influential 'Stochastic Parrots' paper, debunked common misconceptions about the term on its five-year anniversary. The paper, which argued that large language mode…
Despite advances in deep learning, models like AlphaFold that transform science remain rare because training on human text, which is downstream of hard-won knowledge, differs from training on frontier…
Google DeepMind CEO Demis Hassabis warned that artificial intelligence is overhyped in the short term but underappreciated in the long term, predicting a 'new golden era of discovery' in medicine, ene…
Australian tech entrepreneur Paul Conyngham used AI tools including ChatGPT and AlphaFold to design a personalized mRNA cancer vaccine for his dog Rosie, which shrank her tumors after conventional tre…
AI professor Carolyn Jean, who carries a high-risk cancer mutation, argues against rapid AI development despite potential benefits like curing cancer. She criticizes AI lab leaders' predictions of imm…
Anthropic published research showing frontier AI models achieved as low as 16.9% accuracy on identical viral sequence queries due to broken data infrastructure, not model limitations. A deterministic …